Hoque KM, Chen L, Leung GP, Tse C-M. A purine-selective nucleobase/nucleoside transporter in PK15NTD cells. Am J Physiol Regul Integr Comp Physiol 294: R1988-R1995, 2008. First published April 16, 2008 doi:10.1152/ajpregu.00016.2008.-Nucleoside and nucleobase transporters are important for salvage of purines and pyrimidines and for transport of their analog drugs into cells. However, the pathways for nucleobase translocation in mammalian cells are not well characterized. We identified an Na-independent purineselective nucleobase/nucleoside transport system in the nucleoside transporter-deficient PK15NTD cells. This transport system has 1,000-fold higher affinity for nucleobases than nucleosides with Km values of 2.5 Ϯ 0. 3 H]guanine (0.05 M) was inhibited by other nucleobases and nucleobase analog drugs (at 0.5-1 mM in the order of potency): 6-mercaptopurine ϭ thioguanine ϭ guanine Ͼ adenine ϾϾϾ thymine ϭ fluorouracil ϭ uracil. Cytosine and methylcytosine had no effect. Nucleoside analog drugs with modification at 2Ј and/or 5 positions (all at 1 mM) were more potent than adenosine in competing the uptake of [ 3 H]guanine: 2-chloro-2Ј-deoxyadenosine Ͼ 2-chloroadenosine Ͼ 2Ј3Ј-dideoxyadenosine ϭ 2Ј-deoxyadenosine Ͼ 5-deoxyadenosine Ͼ adenosine. 2-Chloro-2Ј-deoxyadenosine and 2-chloroadenosine inhibited [
transport system has a high affinity for hypoxanthine (ϳ1 M) and is inhibited by uracil, thymine, and guanine but not by adenine. Recently, Kato et al. (15) described two Na-dependent nucleobase transport systems with distinct substrate selectivity in rat Sertoli cells: the Na-dependent guanine transport and the Na-dependent uracil transport. The former is inhibited by purine nucleosides and nucleobases but not by pyrimidines, and the latter is inhibited by pyrimidine nucleosides and nucleobases but not by purines. An Na-independent nucleobase transport has been reported in human erythrocytes, JAP2, CCRF-CEM, primary human cardiac microvascular endothelial cells, and LLC-PK1 cells (1, (12) (13) (14) (15) (16) (17) . The affinities of adenine, guanine, and hypoxanthine for the Na-independent nucleobase transport system are 13-30 M, 18 -37 M, and 90 -120 M, respectively (4, 14) . It is inhibited by the opium alkaloid drug papaverine but not by the ENT inhibitors nitrobenzylthioinosine {6-[(4-nitrobenzyl)thiol]-9-␤-D-ribofuranosylpurine} (NBMPR), dipyridamole, and dilazep.
Little is known about the molecular basis of nucleobase transport in mammalian cells, and no functional mammalian nucleobase transporter has been cloned. Although the human and rat Na-dependent ascorbic transporters SVCT1 and SVCT2 have been defined as orthologs of bacterial nucleobase transporters in mammals, these proteins do not transport nucleobases (20, 23) . On the other hand, of the cloned equilibrative nucleoside transporters, ENT2 is capable of transporting nucleobases and nucleosides, although the affinity for nucleobase transport of ENT2 has not been defined (4, 8, 24) . The multifunctional transporter mouse ENT4/plasma membrane monoamine transporter (PMAT) is also found to transport adenine with a K m of 2.6 mM (2). However, its human ortholog lacks the adenine transport activity (2) .
Our laboratory has previously generated nucleoside transporter-deficient (PK15NTD) cells (24 3 H]guanosine uptake pathway. We now demonstrate in these cells the presence of a purine-selective nucleobase/nucleoside transport system, which is resistant to ENT inhibitors but is inhibited by the organic cation transport inhibitor decynium-22 and by papaverine.
METHODS
Cell culture. PK15NTD cells were derived from the porcine PK15 cells, which were obtained from American Type Culture Collection (Manassas, VA) (24) . Both PK15 and PK15NTD cells were cultured in Eagle's minimal essential medium/Earle's balanced salt solution (1:1) with 0.1 mM nonessential amino acids, 1 mM pyruvate, 5% fetal bovine serum, penicillin (50,000 units/l), and streptomycin (50 mg/l) at 37°C with 5% CO 2-95% air. For uptake experiments, cells were grown on 24- 7.4) . The cells were solubilized in 0.5 ml of 5% Triton X-100, and radioactivity was measured in a ␤-scintillation counter. The protein contents of representative monolayers were determined spectrophotometrically by means of a commercial BCA assay (Sigma). Briefly, reagent A (BCA solution) and reagent B (copper sulfate solution) were mixed in a proportion of 50:1. Then 0.9 ml of resulting solution was added to 0.1 ml of protein sample, and the resulting mixture was incubated at 60°C for 1 h. The samples were read at OD 562nm, and the protein concentration was determined from the standard curve (5 to 100 g).
Data analysis. Nucleobase/nucleoside uptake data was expressed as means Ϯ SE of at least three experiments performed in triplicate. 
RESULTS
Uridine is a well-characterized substrate of the equilibrative nucleoside transporters ENT1 and ENT2. PK15NTD cells lack endogenous NBMPR-inhibitable uridine uptake, confirming the absence of ENT1 and ENT2 in these cells (24) . However, these cells demonstrated uptake of the purine nucleosides (10 M (n ϭ 18), respectively. As shown in Fig. 1A , nonradioactive adenosine inhibited [ 3 H]adenosine (10 M) uptake in a concentration-dependent manner with 17 Ϯ 6% inhibition at 1 mM and 50 Ϯ 6% inhibition at 5 mM. Similarly, guanosine (1 mM) inhibited the [ 3 H]adenosine uptake by 45 Ϯ 5%. This uptake of [ 3 H]adenosine was inhibited by 15% with 100 M NBMPR, but not by 100 M dipyridamole and dilazep, the concentration that is sufficient to completely inhibit ENT1 and ENT2.
Recently, the function of ENT4/PMAT has been reported (2, 10). ENT4/PMAT is a multifunctional transporter that accepts adenosine, monoamines, and organic cations as substrates and is inhibited by the organic cation transport inhibitor decynium-22 and by the dopamine transporter inhibitor GBR12935 (2, 9, 10, 27 ). Therefore, we tested whether adenosine uptake was inhibited by decynium-22 and GBR12935 (2, 9, 10). As shown in Fig. 1A , respectively. The [
3 H]adenosine uptake was not inhibited by pyrimidine nucleosides: thymidine, cytidine, and uridine (all at 1 mM) (Fig. 3) . Unexpectedly, the purine nucleobases adenine and guanine inhibited (Fig. 4B) , respectively. N ϭ 4 cells. Competing nucleosides and nucleobases were at 1 mM except guanine (0.5 mM). These nucleosides and nucleobases were added simultaneously with [ 3 H]adenosine (10 M, 2 Ci/ml, 5 min uptake). Each value is the mean Ϯ SE of 4 experiments. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001; NS, not significant.
(1 mM) to inhibit [ 3 H]guanine uptake (0.05 M) was tested. As shown in Fig. 6 , the nonradioactive nucleobases inhibited [ 3 H]guanine uptake with a rank order of potency guanine (98 Ϯ 2%) Ϸ adenine (93 Ϯ 3%) ϾϾϾ thymine (58 Ϯ 2%) Ͼ uracil (42 Ϯ 3%) ϾϾ cytosine (10 Ϯ 4%), which did not significantly inhibit the [ 3 H]guanine uptake. This order of potency strongly suggests the presence of a purine-selective, decynium-22-sensitive nucleobase/nucleoside transport system in PK15NTD cells. For nucleosides, only guanosine (43 Ϯ 2%) and adenosine (29 Ϯ 3%) significantly inhibited the [ 3 H]guanine uptake, whereas inosine, thymidine, uridine, and cytidine had no effect. While the organic cations, 1-methyl-4-phenylpyridinium iodide (MPP), and TEA did not inhibit the To evaluate the ability of the nucleobase/nucleoside transporter in the uptake of nucleobase and nucleoside analog drugs, we tested the ability of these drugs in competing the uptake of [ 3 H]guanine (0.05 M) (Fig. 7) . The guanine analogs, 6-mercaptopurine and thioguanine, inhibited Ͼ 95%, while the uracil analog 5-fluorouracil inhibited 46 Ϯ 6% and the cytosine analog, methylcytosine had no effect. While 1 mM adenosine inhibited 20% (Fig. 1) , adenosine analog drugs with modification at 2Ј and/or 5 positions (all at 1 mM) were more potent than adenosine in competing the uptake of [ 3 H]guanine: 2-chloro-2Ј-deoxyadenosine (Ͼ 95%) Ͼ 2-chloroadenosine (90 Ϯ 1%) ϾϾ 2Ј3Ј-dideoxyadenosine (70 Ϯ 3%) ϭ 2Ј-deoxyadenosine (68 Ϯ 4%) ϾϾ 5-deoxyadenosine (35 Ϯ Fig. 4 The plasma membrane adenosine and monoamine transporter ENT4 is stimulated by acidic pH. In contrast, the nucleobase/nucleoside transporter was not affected by the alkaline pH (pH ϭ 8.0) but was inhibited by acidic pH (pH ϭ 5.5) (Fig. 9) .
PK15NTD cells are derived from porcine PK15 cells by mutagenesis with ethylmethanesulfonate (24) . To eliminate the possibility that the decynium-22-sensitive nucleobase/ nucleoside transport resulted from modification of transporter functions by ethylmethanesulfonate in PK15 cells, we tested whether PK15 cells expressed the decynium-22-sensitive nucleobase/nucleoside transport identical to that of PK15NTD cells. Since ENT1 is present in PK15 cells (24) H]guanine was measured in the presence of 100 nM NBMPR, which completely inhibited the endogenous ENT1. Table 1 compares the apparent K m values for adenine, guanine, and adenosine of the wild-type PK15 and the PK15NTD cells.
DISCUSSION
Nucleosides and nucleobase transporters are important for salvage of purines and pyrimidines. Although the nucleoside transporting pathways have been defined and the proteins responsible for transport of nucleosides have been cloned (8) , little is known about mammalian nucleobase transporters and nucleobase translocation pathways. In the present study, we identified a novel Na-independent purine-selective nucleobase/ nucleoside transporter that is inhibited by papaverine and decynium-22. Our results suggest that adenosine, guanosine, adenine, and guanine are transported by the same carrier. First, the transport of purine nucleobases/nucleosides was resistant to inhibition by NBMPR, dilazep, and dipyridamole. Second, adenine, guanine, adenosine, and guanosine inhibited the uptake of each other (Figs. 3 and 6) . Third, the IC 50 values of decynium-22 inhibition of PK15 cells also exhibited decynium-22-sensitive uptake of adenine, guanine, and adenosine with similar affinities ( Table  1 ), confirming that the decynium-22-sensitive nucleobase/nucleoside transporter is not due to the artifact of mutagenesis of the PK15 cells with ethylmethanesulfonate, which modifies DNA by alkylation (18, 27) . When comparing these K m values of adenosine and guanosine uptake by the nucleobase/nucleoside transporter with those of ENT1 and ENT2, the K m value for adenosine of the nucleobase/nucleoside transporter is numerically two orders of magnitudes higher than that of ENT1 (K m ϭ 0.04 mM) and 30-fold higher than that of ENT2 (K m ϭ 0.14 mM) (8, 24) . While the K m value for guanosine of the nucleobase/nucleoside transporter is 30-fold higher than that of ENT1 (K m ϭ 0.14 mM), it is threefold lower than that of ENT2 (K m ϭ 2.7 mM), suggesting that the nucleobase/nucleoside transporter has a higher affinity for guanosine than that of ENT2 and may play a more physiological relevant role than ENT2 in regulating the physiological functions of guanosine.
Purine-selective nucleobase transporters have also been described in mammalian erythrocytes, T-lymphoblast JPA2, CCRF-CEM, OK, primary human cardiac microvascular endothelial cells, and LLC-PK1 cells (1, 4, 12, 13, 19) . Although none of these nucleobase transporters is shown to transport nucleosides, adenosine inhibits [
3 H]hypoxanthine uptake in cardiac microvascular cells with a K i of 1.2 mM, suggesting that the nucleobase transporter in human cardiac microvascular cells might also transport adenosine with low affinity (4). The affinity constants (K m or K i ) of these nucleobase transporters are 13-30 M for adenine, and 18 -37 M for guanine, which are five-to twelvefold and three-to fivefold, respectively, numerically higher than those of the nucleobase/nucleoside transporter described in the present study. Papaverine (500 M) inhibited the nucleobase/nucleoside transport in PK15NTD cells. It also inhibits the adenine uptake in erythrocytes and LLC-PK1 cells (13, 16) , although it is not known whether papaverine inhibits the nucleobase transport in JAP2, human cardiac microvascular cells and CCRF-CEM cells.
The nucleobase/nucleoside transporter shares many properties similar to the recently characterized multifunctional ENT4/ PMAT (2, 9, 10). First, both the uptake of [ nucleobase/nucleoside transporter and by the cloned ENT4/ PMAT are Na-independent and inhibited by decynium-22 and GBR12935 (2, 9, 10) . Second, serotonin inhibits the uptake of [ 3 H]adenosine by the nucleobase/nucleoside transporter and by the cloned ENT4/PMAT, suggesting that serotonin is a substrate of both transport systems (2, 9, 10) . Third, adenine is a substrate of both mouse ENT4/PMAT and the nucleobase/ nucleoside transporter (2) . However, the nucleobase/nucleoside transporter has characteristics that are distinct from ENT4/ PMAT: 1) the uptake of [
